China News Service, September 17 According to the website of the National Medical Security Administration, the Supreme People's Court and the National Medical Insurance Administration recently signed the "Memorandum of Cooperation on Information Exchange and Sharing of Commercial Bribery Cases in the Medical Field".
The main content is to establish a regular notification system for commercial bribery cases in the pharmaceutical field, actively expand the application of judicial results of commercial bribery cases in the pharmaceutical field in the field of pharmaceutical prices and recruitment, jointly promote information exchange and sharing at all levels of the system, and continue to deepen the governance of commercial bribery in the pharmaceutical field. Cooperation.
In accordance with the requirements of the "Opinions of the Central Committee of the Communist Party of China and the State Council on Deepening the Reform of the Medical Security System", the National Medical Insurance Administration has actively promoted the establishment of a medical price and recruitment credit evaluation system. It has recently issued guidelines requiring all localities to establish and implement credit evaluations by the end of 2020 The system, under the cooperation framework of the National Medical Security Administration and relevant departments, takes pharmaceutical commercial bribery as the entry point, relies on the centralized pharmaceutical procurement market, and strengthens the control of pharmaceutical commercial bribery, promotes the legal and honest operation of pharmaceutical enterprises, and promotes reasonable prices of medicines The return will better ensure that the people have medical treatment.